Francesco Secchi1, Elda Chiara Resta2, Paola Maria Cannaò2, Silvia Tresoldi3, Gianfranco Butera4, Mario Carminati4, Francesco Sardanelli5,6. 1. Unit of Radiology, IRCCS Policlinico San Donato, Via Morandi 30, 20097, San Donato Milanese, Milan, Italy. francesco.secchi@grupposandonato.it. 2. Scuola di Specializzazione in Radiodiagnostica, Università degli Studi di Milano, Via Festa del Perdono 7, 20100, Milan, Italy. 3. Azienda Ospedaliera San Paolo, Unit of Diagnostic and Interventional Radiology, via A. di Rudinì 8, 20142, Milan, Italy. 4. Unit of Paediatric Cardiology, IRCCS Policlinico San Donato, Via Morandi 30, 20097, San Donato Milanese, Milan, Italy. 5. Unit of Radiology, IRCCS Policlinico San Donato, Via Morandi 30, 20097, San Donato Milanese, Milan, Italy. 6. Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Mangiagalli 31, 20133, Milan, Italy.
Abstract
OBJECTIVES: To investigate follow-up after percutaneous pulmonary valve implantation (PPVI). METHODS: Forty patients with pulmonary conduit dysfunction (males/females 24/16; 21 ± 08 years; 12 tetralogy of Fallot, 11 aortic valve disease, 17 other congenital heart disease) were planned for CMR before PPVI and repeated 7 times up to 48 months. CMR prospective results regarded: pressure gradient (PG) and regurgitation fraction (RF); end-diastolic volume, end-systolic volume, and stroke volume indexed to body surface area (EDVI, ESVI, and SVI); ejection fraction (EF) of right and left ventricles (RV, LV). A Friedman test was used for comparisons. RESULTS: Overall, PG (31 ± 06 to 16 ± 4 mmHg), RF (16 ± 17 to 0.3 ± 1 %), RVEDVI (82 ± 38 to 58 ± 12 ml/m(2)), and RVESVI (44 ± 12 to 30 ± 13 ml/m(2)) declined (p < 0.001), RVEF (49 ± 13 to 58 ± 12 %) and RVSVI (from 38 ± 14 to 40 ± 8 ml/m(2)) increased (p < 0.001), LVEDVI (67 ± 17 to 73 ± 18 ml/m(2)) and LVSVI (37 ± 11 to 43 ± 10 ml/m(2)) increased (p = 0.034 and p < 0.001). Two patients had valve fracture at 24 and 36 months and underwent surgery. One patient had stent restenosis at 24 months and underwent percutaneous retreatment. Baseline/follow-up CMR did not predict PPVI failure. CONCLUSIONS: CMR demonstrated restored pulmonary conduit function, reduced RV volumes and increased RV and LV function but did not predict valve fracture/restenosis. KEY POINTS: • A CMR 4-year follow-up after PPVI showed restored pulmonary conduit function • RV volumes were significantly reduced • RV function was significantly better in terms of increased EF and SVI • LV function was significantly better in terms of increased EDVI and SVI • Baseline/follow-up CMR did not predict three cases of PPVI failure.
OBJECTIVES: To investigate follow-up after percutaneous pulmonary valve implantation (PPVI). METHODS: Forty patients with pulmonary conduit dysfunction (males/females 24/16; 21 ± 08 years; 12 tetralogy of Fallot, 11 aortic valve disease, 17 other congenital heart disease) were planned for CMR before PPVI and repeated 7 times up to 48 months. CMR prospective results regarded: pressure gradient (PG) and regurgitation fraction (RF); end-diastolic volume, end-systolic volume, and stroke volume indexed to body surface area (EDVI, ESVI, and SVI); ejection fraction (EF) of right and left ventricles (RV, LV). A Friedman test was used for comparisons. RESULTS: Overall, PG (31 ± 06 to 16 ± 4 mmHg), RF (16 ± 17 to 0.3 ± 1 %), RVEDVI (82 ± 38 to 58 ± 12 ml/m(2)), and RVESVI (44 ± 12 to 30 ± 13 ml/m(2)) declined (p < 0.001), RVEF (49 ± 13 to 58 ± 12 %) and RVSVI (from 38 ± 14 to 40 ± 8 ml/m(2)) increased (p < 0.001), LVEDVI (67 ± 17 to 73 ± 18 ml/m(2)) and LVSVI (37 ± 11 to 43 ± 10 ml/m(2)) increased (p = 0.034 and p < 0.001). Two patients had valve fracture at 24 and 36 months and underwent surgery. One patient had stent restenosis at 24 months and underwent percutaneous retreatment. Baseline/follow-up CMR did not predict PPVI failure. CONCLUSIONS: CMR demonstrated restored pulmonary conduit function, reduced RV volumes and increased RV and LV function but did not predict valve fracture/restenosis. KEY POINTS: • A CMR 4-year follow-up after PPVI showed restored pulmonary conduit function • RV volumes were significantly reduced • RV function was significantly better in terms of increased EF and SVI • LV function was significantly better in terms of increased EDVI and SVI • Baseline/follow-up CMR did not predict three cases of PPVI failure.
Entities:
Keywords:
Cardiac magnetic resonance; Congenital heart disease; Percutaneous pulmonary valve implantation; Pulmonary conduit; Right and left ventricles
Authors: Doff B McElhinney; William E Hellenbrand; Evan M Zahn; Thomas K Jones; John P Cheatham; James E Lock; Julie A Vincent Journal: Circulation Date: 2010-07-19 Impact factor: 29.690
Authors: B Eyskens; T Reybrouck; J Bogaert; S Dymarkowsky; W Daenen; M Dumoulin; M Gewillig Journal: Am J Cardiol Date: 2000-01-15 Impact factor: 2.778
Authors: M A Gatzoulis; J T Elliott; V Guru; S C Siu; M A Warsi; G D Webb; W G Williams; P Liu; P R McLaughlin Journal: Am J Cardiol Date: 2000-12-15 Impact factor: 2.778
Authors: Kirk R Kanter; Jason M Budde; W James Parks; Vincent K H Tam; Shiva Sharma; Willis H Williams; Derek A Fyfe Journal: Ann Thorac Surg Date: 2002-06 Impact factor: 4.330
Authors: Christopher M Kramer; Jörg Barkhausen; Scott D Flamm; Raymond J Kim; Eike Nagel Journal: J Cardiovasc Magn Reson Date: 2013-10-08 Impact factor: 5.364
Authors: Giovanni Di Leo; Ida Daniela D'Angelo; Marco Alì; Paola Maria Cannaò; Giovanni Mauri; Francesco Secchi; Francesco Sardanelli Journal: Radiol Med Date: 2016-11-22 Impact factor: 3.469
Authors: Francesco Secchi; Marco Alì; Marcello Petrini; Francesca Romana Pluchinotta; Andrea Cozzi; Mario Carminati; Francesco Sardanelli Journal: Radiol Med Date: 2018-01-22 Impact factor: 3.469